Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
In Phase 2 trials, retatrutide at 12 mg produced an average 24.2% body weight loss at 48 weeks
YMSER VE KTMSER SENARYOLAR Raporun iyimser senaryosu, GLP-1 tedavilerinin geni apta benimsenmesini ve hastalarn tedaviye balln gerektiriyor
Follow-up showed no developmental concerns
The effect was observed in a 12-month longitudinal follow-up
Your first point of contact for any concerns about your trial medication should be your trial team , who are best placed to assess whether symptoms may be related to the investigational medicine and to advise on next steps
US$ 25.39
US$ 22.71
US$ 22.12
US$ 20.96
